Report Ocean has published a new report on the Saudi Arabia Active Pharmaceutical Ingredients (API) Market, delivering an extensive analysis of key factors such as market restraints, drivers, and ...

Chinese pharma giant Shanghai Pharmaceuticals is in talks with major Indian pharmaceutical companies for greater access to ...

STEERlife and Callidus Research Laboratories join forces to accelerate drug development for global markets, combining hot melt extrusion and pharmaceutical expertise.

Joint efforts promise innovative drug solutions and enhanced offerings while enabling comprehensive development of active ...

In the past, we used to export a lot of APIs (Active Pharmaceutical Ingredients) and in the mid chemical products (sector) to ...

About Invizyne Technologies, Inc. Invizyne Technologies, Inc. is a cell-free enzyme-based biomanufacturing technology company ...

As of now, no API (Active Pharmaceutical Ingredient) for medical cannabis has been registered." She explained that medical ...

Invizyne is redefining biomanufacturing by leveraging cell-free, multi-step, enzyme-based systems to efficiently transform natural or renewable resources into highly sought after biochemicals, such as ...

The U.S. Food and Drug Administration is taking the first step to remove an ingredient in non-prescription cold medicines ...

Germany pharmaceutical company BioNTech, which shot to global prominence after its early coronavirus vaccine, has boosted its ...

Y-o-Y Growth and Strong Performance in 2024 The Small Molecule API market is anticipated to exhibit a Y-o-Y growth of 4.6% in ...

Indian generic drugmaker Lupin reported a bigger-than-expected rise in second-quarter profit on Thursday, driven by strong demand for its respiratory and diabetes management drugs.